This page includes the latest FDA filings for Portola Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | PTLA | DUNS 142296016 |
Device Company | Device | Date |
---|---|---|
Portola Pharmaceuticals, Inc., Patheon, Inc., AndersonBrecon Inc. | Prescription Medication | 2019-08-01 |
Portola Pharmaceuticals, Inc., Patheon, Inc., AndersonBrecon Inc. | Prescription Medication | 2019-04-03 |
Portola Pharmaceuticals, Inc. | BEVYXXA | 2017-07-07 |
Portola Pharmaceuticals, Inc. | BEVYXXA | 2017-07-07 |
NCAGE Code | 5XNN2 | PORTOLA PHARMACEUTICALS, INC. |
CAGE Code | 5XNN2 | PORTOLA PHARMACEUTICALS, INC. |
S.A.M. Registration | 5XNN2 [142296016] | PORTOLA PHARMACEUTICALS, INC. |
SEC | 0001269021 | PORTOLA PHARMACEUTICALS INC of DELAWARE |